Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018723

Expand all

DEPAKOTE (DIVALPROEX SODIUM)
EQ 125MG VALPROIC ACID
Marketing Status: Prescription
Active Ingredient: DIVALPROEX SODIUM
Proprietary Name: DEPAKOTE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: EQ 125MG VALPROIC ACID
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018723
Product Number: 003
Approval Date: Oct 26, 1984
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
DEPAKOTE (DIVALPROEX SODIUM)
EQ 250MG VALPROIC ACID
Marketing Status: Prescription
Active Ingredient: DIVALPROEX SODIUM
Proprietary Name: DEPAKOTE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: EQ 250MG VALPROIC ACID
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018723
Product Number: 001
Approval Date: Mar 10, 1983
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
DEPAKOTE (DIVALPROEX SODIUM)
EQ 500MG VALPROIC ACID
Marketing Status: Prescription
Active Ingredient: DIVALPROEX SODIUM
Proprietary Name: DEPAKOTE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: EQ 500MG VALPROIC ACID
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018723
Product Number: 002
Approval Date: Mar 10, 1983
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English